The distinct effects of metformin and imeglimin on high glucose-induced alterations in metabolic function and reactive oxygen species production in mouse Schwann cells are modulated by pemafibrate and/or fatty acid-binding proteins.
BackgroundImeglimin (Ime), the first in a novel class of antidiabetic agents, has potential therapeutic effects on diabetic peripheral neuropathy (DPN). This study aimed to evaluate and compare the effects on cellular metabolic function and reactive oxygen species (ROS) levels in high glucose-treate...
Saved in:
| Main Authors: | Hiroshi Ohguro, Megumi Higashide, Nami Nishikiori, Toshifumi Ogawa, Masato Furuhashi, Tatsuya Sato, Megumi Watanabe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cellular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2025.1634262/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pemafibrate Induces a Low Level of PPARα Agonist-Stimulated mRNA Expression of ANGPTL4 in ARPE19 Cell
by: Hiroshi Ohguro, et al.
Published: (2024-12-01) -
Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic β‐like cells and rather enhances gain in β cell identity gene sets
by: Tasuku Imada, et al.
Published: (2025-04-01) -
Safety and Efficacy of Imeglimin in Type 2 Diabetes Individuals with Metformin Intolerance: A Case-Control Study
by: Prabhat Agrawal, et al.
Published: (2025-01-01) -
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data
by: Jumpei Ito, et al.
Published: (2025-04-01) -
The role of fatty acid-binding proteins in evaluating kidney involvement in patients with ankylosing spondylitis
by: L. V. Plenkina, et al.
Published: (2020-02-01)